Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Aratana Therapeutics Inc

+ Add to Watchlist

PETX:US

13.0800 USD 0.1600 1.21%

As of 12:08:24 ET on 05/05/2015.

Snapshot for Aratana Therapeutics Inc (PETX)

Open: 13.1500 Day's Range: 12.7100 - 13.1700 Volume: 79,000
Previous Close: 13.2400 52wk Range: 9.2000 - 20.6300 1-Yr Rtn: -5.84%

Stock Chart for PETX

No chart data available.
  • PETX:US 13.1300
  • 1D
  • 1M
  • 1Y
13.2400
Interactive PETX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PETX

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.2395
Est. EPS (USD) (12/2015) -1.6290
Est. PEG Ratio -
Market Cap (M USD) 462.21
Shares Outstanding (M) 34.91
30 Day Average Volume 222,879
Price/Book (mrq) 2.4602
Price/Sale (ttm) 508.9300
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/07/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PETX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for PETX

Aratana Therapeutics, Inc. develops biomedical therapeutics for animals. The Company offers products to treat the pain and inflammation associated with osteoarthritis in pets. Aratana Therapeutics markets its products in the United States.

Steven St PeterPresident/CEO/Co-FounderCraig A ToomanCFO/Treasurer
Ernst HeinenChief Development OfficerLinda RhodesChief Scientific Officer
More Company Profile & Key Executives for PETX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil